(Q38448958)

3 September 2017

Survivin expression is associated with features of biologically aggressive prostate carcinoma (English)

1 reference

3 September 2017

2

Yair Lotan

1 reference

3 September 2017

1

Shahrokh F Shariat

1 reference

3 September 2017

5

Claus G Roehrborn

1 reference

3 September 2017

Hossein Saboorian

3

1 reference

3 September 2017

Seyed M Khoddami

series ordinal

4

1 reference

3 September 2017

Kevin M Slawin

series ordinal

6

1 reference

3 September 2017

Raheela Ashfaq

series ordinal

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

3 September 2017

1 reference

3 September 2017

100

1 reference

3 September 2017

751-757

1 reference

3 September 2017

4

1 reference

Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Inhibitors of apoptosis proteins in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Cancer gene therapy using a survivin mutant adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Fresh tissue harvest for research from prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20039

7 January 2021

Identifiers

DOI

10.1002/CNCR.20039

1 reference

3 September 2017

1 reference